Sterling Biotech: NCLAT says payments to settle dues to be certified as clean money by ED Medical Dialogues Bureau7 Sept 2019 9:30 AM ISTThe NCLAT further said to Sterling Biotech counsel: "You will have to get the verification done as to whether the money is genuine nor not".New Delhi:...
Roche touts drugs pipeline, rules out Merger and Acquisition just to boost sales Medical Dialogues Bureau7 Sept 2019 9:15 AM ISTRoche has twice upgraded 2019 sales forecasts, the latest time to mid- to high-single-digit percentage rate growth, as medicines including Ocrevus for...
Sumitomo Dainippon Pharma to acquire 10pc stake in Roivant Sciences for USD 3 billion Medical Dialogues Bureau7 Sept 2019 9:00 AM ISTThe deal, which will open up new drug lines for Sumitomo Dainippon, will also give it the option to acquire interests in an additional six businesses,...
Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units Medical Dialogues Bureau6 Sept 2019 1:03 PM ISTThe establishment inspection report (EIR) from US Food and Drug Administration (USFDA) is for company's active pharmaceutical ingredients units 1 and...
SEBI directs Sun Pharma to undergo forensic audit of financial statements for FY16-18 Medical Dialogues Bureau6 Sept 2019 9:50 AM ISTSun Pharma, however, did not provide any specific details on the reasons for the Securities and Exchange Board of India to order the forensic...
Unichem Labs successfully completes USFDA inspection of Pithampur facility Medical Dialogues Bureau6 Sept 2019 9:45 AM IST"The United States Food and Drug Administration (USFDA) conducted an inspection at the Company's Pithampur, Active Pharmaceutical Ingredients (APIs)...
Landmark Trial for Dapagliflozin: AstraZeneca diabetes drug Forxiga shows benefits in patients with heart failure Farhat Nasim6 Sept 2019 9:17 AM ISTDapagliflozin(Forxiga) is currently available and indicated for type 2 diabetes in India and not yet approved for treatment for heart failure in...
Bayer disagrees with German Government decision to ban Glyphosate from end of 2023 Medical Dialogues Bureau6 Sept 2019 9:00 AM IST"Such a ban would ignore the overwhelming scientific assessments of competent authorities around the world that have determined for more than 40 years...
Dr Reddys unveils generic version of Zyban ER tablets in US Medical Dialogues Bureau5 Sept 2019 5:01 PM ISTThe company has launched Bupropion hydrochloride extended-release tablets USP (SR), approved by the United States Food and Drug Administration...
Glenmark Pharma to restructure itself into 3 entities in 2019: Chairman Glenn Saldanha Medical Dialogues Bureau5 Sept 2019 9:45 AM ISTIn his message to the company's shareholders, Glenmark Pharma Chairman and MD Glenn Saldanha said the three entities will focus on different verticals...
AstraZeneca gets Chinese marketing nod for Tagrisso to treat lung cancer Medical Dialogues Bureau5 Sept 2019 9:30 AM ISTChina approved Tagrisso as a first-line treatment for adults with non-small cell lung cancer patients whose tumours have certain genetic mutations,...
Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm Medical Dialogues Bureau5 Sept 2019 9:15 AM ISTZURICH: Novartis sees cell and gene therapies accounting for up to 15% of its total revenue in the midterm from a much lower level at present, a Swiss...
